Pleurisy with pneumothorax due to CAM-resistant MAC lung disease.

Authors :: Nukui Y
Kawahara T
Hanzawa S
Source :: Respirology case reports [Respirol Case Rep] 2022 Jun 14; Vol. 10 (7), pp. e0993. Date of Electronic Publication: 2022 Jun 14 (Print Publication: 2022).
Publication Year :: 2022
Abstract: A 72-year-old man received rifampicin, ethambutol and sitafloxacin to treat clarithromycin (CAM)-resistant Mycobacterium avium complex (MAC) lung disease. He was admitted because of fever. Pneumothorax and pleural effusion were present in the right lung, and a new consolidation appeared in the right upper lobe. Based on positive culture of the pleural effusion for CAM-resistant M. avium and findings on chest computed tomography, he was diagnosed with pleurisy due to M. avium , with rupture of the subpleural lung parenchymal lesion into the pleural space. Additional treatment with streptomycin (SM) improved the patient's high-grade fever. SM might be effective for pleurisy caused by CAM-resistant MAC lung disease.<br />Competing Interests: None declared.<br /> (© 2022 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology.)